COO

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Cooper Companies, Inc.

CooperCompanies ("Cooper") is a global medical device company. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries.
CEO
Albert White
Employees
12000
Headquarters

6101 Bollinger Canyon Rd Ste 500
San Ramon, California 94583
Phone: 19254603600
www.coopercos.com

News

Quant Ratings Updated on 103 Stocks
Nov 15, 2022 21:30pm

Last week the markets saw their best single-session gain in more than two years as investors celebrated the favorable Consumer Price Index ( CPI ) reading. And then today’s Producer Price Index (PPI) had Wall Street cheering again. PPI increased 0.2% in October, which was less than economists’ expectations for a 0.4% increase. PPI rose 8% year-over-year, which was also below economists’ forecasts for an 8.4% rise. Core PPI, which excludes food, energy and trade services, climbed 0.2% in October and 5.4% year-over-year. Out of the S&P 500, Dow and NASDAQ, the tech-heavy NASDAQ staged the biggest rally – as of this writing, it’s up more than 1% today and up nearly 8% since November 4. On the flip side, the 10-year Treasury fell below 3.8% this morning and is well off its November high of 4.22%. As investors dip their toes back into the tech sector, some tech stocks are beginning to find their groove again in Portfolio Grader , too. Case in point: United Microelectronics Corp. ( UMC ). For the last several months, this leading global semiconductor foundry has come under pressure along with the semiconductor sector.


Source:InvestorPlace
The Cooper Companies – Consensus Indicates Potential 8.5% Upside
Nov 15, 2022 15:29pm

The Cooper Companies found using ticker (COO) now have 10 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 560 and 280 with a mean TP of 351.8. With the stocks previous close at 324.32 this is indicating there is a potential upside of 8.5%. The day 50 moving average is 277.26 while the 200 day moving average is 336.2. The company has a market cap of $15,519m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $16,834m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk
Cooper Companies: Questions On Future Earnings Upside (NYSE:COO)
Nov 04, 2022 21:42pm

Cooper Companies has a way to go to recover from a heavy drawdown period from FY21 to date. Click here to read our latest analysis of COO stock.


Source:Seeking Alpha
The Cooper Companies – Consensus Indicates Potential 36.1% Upside
Oct 25, 2022 14:04pm

The Cooper Companies with ticker code (COO) now have 10 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 560 and 280 calculating the mean target price we have 353.8. With the stocks previous close at 259.99 this indicates there is a potential upside of 36.1%. The 50 day moving average now sits at 287.89 and the 200 day MA is 345.98. The market capitalisation for the company is $12,760m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $17,364m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk
The Cooper Companies – Consensus Indicates Potential 42.3% Upside
Oct 18, 2022 11:42am

The Cooper Companies with ticker code (COO) now have 10 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 560 and 280 with the average target price sitting at 353.8. Now with the previous closing price of 248.67 this indicates there is a potential upside of 42.3%. The day 50 moving average is 293.69 and the 200 moving average now moves to 349.16. The market capitalisation for the company is $12,835m. Company Website: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $18,262m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk
Jefferies Downgrades Cooper Companies to Hold
Oct 11, 2022 20:57pm

https://www.investing.com/news/pro/jefferies-downgrades-cooper-companies-to-hold-432SI-2909899


Source:Investing.com
The Cooper Companies – Consensus Indicates Potential 38.8% Upside
Oct 11, 2022 12:02pm

The Cooper Companies found using ticker (COO) have now 10 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 560 and 280 and has a mean target at 364.3. Now with the previous closing price of 262.39 this would imply there is a potential upside of 38.8%. The 50 day moving average now sits at 300.98 and the 200 day moving average is 353.28. The market cap for the company is $12,714m. You can visit the company''s website by visiting: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $17,652m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk
Cooper Companies PT Lowered to $348 at Citi
Oct 05, 2022 13:14pm

https://www.investing.com/news/pro/cooper-companies-pt-lowered-to-348-at-citi-432SI-2905649


Source:Investing.com
The Cooper Companies – Consensus Indicates Potential 32.2% Upside
Sep 27, 2022 13:12pm

The Cooper Companies found using ticker (COO) have now 10 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 560 and 280 with a mean TP of 364.5. Given that the stocks previous close was at 275.68 this would indicate that there is a potential upside of 32.2%. The day 50 moving average is 309.86 and the 200 day MA is 359.72. The market capitalisation for the company is $13,274m. You can visit the company''s website by visiting: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $17,551m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.


Source:DirectorsTalk